• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗逆转录病毒治疗患者血浆迷迭香酸浓度:基于临床数据的计算探索。

Plasma Concentrations of Rosmarinic Acid in Patients on Antiretroviral Therapy: In Silico Exploration Based on Clinical Data.

机构信息

Department of Pharmacy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.

Center for Medical and Pharmaceutical Investigations and Quality Control, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.

出版信息

Int J Mol Sci. 2024 Feb 13;25(4):2230. doi: 10.3390/ijms25042230.

DOI:10.3390/ijms25042230
PMID:38396908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10888967/
Abstract

Rosmarinic acid (RA) is a phenolic compound with antiviral properties, often encountered in dietary supplements and herbal drugs. Data on the pharmacokinetics of RA are lacking in cases of the chronic use of supplements containing this compound, and only limited data on the metabolism and distribution of RA are available. The aim of the study was to investigate the plasma levels of RA after 12 weeks of use and determine potential interactions of RA and selected antiretroviral drugs. Patients infected with human immunodeficiency virus took a supplement containing RA for 12 weeks, after which the RA concentrations in the plasma samples were analyzed. A detailed in silico analysis was conducted in order to elucidate the potential interactions between RA and the drugs efavirenz, darunavir and raltegravir. It was found that RA can be detected in patients' plasma samples, mainly in the form of sulphoglucuronide. The potential interactions are suggested on the level of liver metabolizing enzymes and efflux P-glycoprotein, with RA competing with antiretroviral drugs as a substrate in metabolism and distribution systems. The present study suggests that the simultaneous use of RA and antiretroviral therapy (containing efavirenz, darunavir or raltegravir) may affect the plasma levels of RA after prolonged supplementation.

摘要

迷迭香酸(RA)是一种具有抗病毒特性的酚类化合物,常存在于膳食补充剂和草药药物中。在慢性使用含有这种化合物的补充剂的情况下,关于 RA 的药代动力学的数据是缺乏的,而且关于 RA 的代谢和分布的有限数据是可用的。本研究的目的是调查在使用 12 周后 RA 在血浆中的水平,并确定 RA 和选定的抗逆转录病毒药物之间的潜在相互作用。感染人类免疫缺陷病毒的患者服用含有 RA 的补充剂 12 周,之后分析血浆样本中的 RA 浓度。为了阐明 RA 与药物依非韦伦、达芦那韦和拉替拉韦之间的潜在相互作用,进行了详细的计算机模拟分析。结果发现,RA 可以在患者的血浆样本中检测到,主要以硫酸葡萄糖醛酸酯的形式存在。潜在的相互作用是在肝代谢酶和外排 P-糖蛋白的水平上提出的,RA 作为代谢和分布系统中的底物与抗逆转录病毒药物竞争。本研究表明,RA 和抗逆转录病毒疗法(含有依非韦伦、达芦那韦或拉替拉韦)的同时使用可能会影响长期补充后 RA 的血浆水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384f/10888967/8e7d79157053/ijms-25-02230-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384f/10888967/966d25720848/ijms-25-02230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384f/10888967/8e7d79157053/ijms-25-02230-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384f/10888967/966d25720848/ijms-25-02230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384f/10888967/8e7d79157053/ijms-25-02230-g002.jpg

相似文献

1
Plasma Concentrations of Rosmarinic Acid in Patients on Antiretroviral Therapy: In Silico Exploration Based on Clinical Data.抗逆转录病毒治疗患者血浆迷迭香酸浓度:基于临床数据的计算探索。
Int J Mol Sci. 2024 Feb 13;25(4):2230. doi: 10.3390/ijms25042230.
2
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients.比较无肝硬化的 HIV-HCV 合并感染患者与 HIV 单一感染患者的依非韦伦、达芦那韦/利托那韦和拉替拉韦血浆浓度。
Infect Dis (Lond). 2015 Sep;47(9):625-36. doi: 10.3109/23744235.2015.1034169. Epub 2015 Apr 15.
3
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.标准剂量拉替拉韦或依非韦伦为基础的抗逆转录病毒治疗方案用于 HIV 和结核病合并感染患者(ANRS 12 300 Reflate TB 2):一项开放标签、非劣效性、随机、3 期临床试验。
Lancet Infect Dis. 2021 Jun;21(6):813-822. doi: 10.1016/S1473-3099(20)30869-0. Epub 2021 Mar 2.
4
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.拉替拉韦与依非韦伦在 HIV 感染的抗逆转录病毒初治孕妇中的应用(NICHD P1081):一项开放标签、随机、对照、4 期临床试验。
Lancet HIV. 2020 May;7(5):e322-e331. doi: 10.1016/S2352-3018(20)30038-2.
5
Bone Mineral Density and Vitamin D Levels in HIV Treatment-Naïve African American Individuals Randomized to Receive HIV Drug Regimens.随机接受抗逆转录病毒药物治疗方案的未接受过抗逆转录病毒治疗的非裔美国个体的骨矿物质密度和维生素D水平
South Med J. 2016 Nov;109(11):712-717. doi: 10.14423/SMJ.0000000000000560.
6
Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的人类免疫缺陷病毒感染患者换用依非韦伦为雷替格韦后肝脂肪变性的变化。
Clin Infect Dis. 2017 Sep 15;65(6):1012-1019. doi: 10.1093/cid/cix467.
7
Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States.美国成年人开始使用包括拉替拉韦或依非韦伦在内的人类免疫缺陷病毒治疗方案后的艾滋病发病或死亡情况。
Clin Infect Dis. 2017 Jun 1;64(11):1591-1596. doi: 10.1093/cid/cix199.
8
Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors.在接受抗逆转录病毒治疗(包括利托那韦增强型蛋白酶抑制剂加两种核苷/核苷酸逆转录酶抑制剂)且病毒学得到抑制的HIV-1感染患者中使用多替拉韦与达芦那韦/利托那韦联合治疗。
HIV Clin Trials. 2016 Feb;17(1):38-47. doi: 10.1080/15284336.2015.1122874. Epub 2016 Jan 5.
9
Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses.拉替拉韦与依非韦伦方案治疗初治 HIV-1 感染患者:96 周疗效、持久性、亚组、安全性和代谢分析。
J Acquir Immune Defic Syndr. 2010 Sep;55(1):39-48. doi: 10.1097/QAI.0b013e3181da1287.
10
Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term.评估孕妇中少数民族群体 HIV 耐药变异频率及与治疗末期病毒学抑制失败的相关性。
PLoS One. 2022 Sep 27;17(9):e0275254. doi: 10.1371/journal.pone.0275254. eCollection 2022.

引用本文的文献

1
The chemoprotective hormetic effects of rosmarinic acid.迷迭香酸的化学保护兴奋效应。
Open Med (Wars). 2024 Oct 21;19(1):20241065. doi: 10.1515/med-2024-1065. eCollection 2024.

本文引用的文献

1
Application of Rosmarinic Acid with Its Derivatives in the Treatment of Microbial Pathogens.迷迭香酸及其衍生物在治疗微生物病原体中的应用。
Molecules. 2023 May 22;28(10):4243. doi: 10.3390/molecules28104243.
2
Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial.含迷迭香酸的蜜蜂花提取物对非痴呆老年人认知功能的影响:一项随机对照试验。
J Alzheimers Dis. 2023;91(2):805-814. doi: 10.3233/JAD-220953.
3
Competitive Metabolism of Polycyclic Aromatic Hydrocarbons (PAHs): An Assessment Using In Vitro Metabolism and Physiologically Based Pharmacokinetic (PBPK) Modeling.
多环芳烃(PAHs)的竞争代谢:体外代谢和基于生理的药代动力学(PBPK)建模的评估。
Int J Environ Res Public Health. 2022 Jul 6;19(14):8266. doi: 10.3390/ijerph19148266.
4
Impact of P-gp and BCRP on pulmonary drug disposition assessed by PET imaging in rats.利用 PET 成像技术评估大鼠肺部药物处置中 P-糖蛋白和乳腺癌耐药蛋白的作用。
J Control Release. 2022 Sep;349:109-117. doi: 10.1016/j.jconrel.2022.06.065. Epub 2022 Jul 8.
5
A Comprehensive Review of Rosmarinic Acid: From Phytochemistry to Pharmacology and Its New Insight.迷迭香酸:从植物化学学到药理学的全面综述及其新见解。
Molecules. 2022 May 20;27(10):3292. doi: 10.3390/molecules27103292.
6
Biomedical features and therapeutic potential of rosmarinic acid.迷迭香酸的生物医学特征和治疗潜力。
Arch Pharm Res. 2022 Apr;45(4):205-228. doi: 10.1007/s12272-022-01378-2. Epub 2022 Apr 7.
7
Radiolabeling, biological distribution, docking and ADME studies of Tc-Ros as a promising natural tumor tracer.放射性标记、生物分布、对接和 ADME 研究表明 Tc-Ros 是一种很有前途的天然肿瘤示踪剂。
Appl Radiat Isot. 2022 Jun;184:110196. doi: 10.1016/j.apradiso.2022.110196. Epub 2022 Mar 30.
8
A Comprehensive In Silico Exploration of Pharmacological Properties, Bioactivities, Molecular Docking, and Anticancer Potential of Vieloplain F from Targeting B-Raf Kinase.基于靶向 B-Raf 激酶的 Vieloplain F 的综合计算机探索:药理学特性、生物活性、分子对接和抗癌潜力。
Molecules. 2022 Jan 28;27(3):917. doi: 10.3390/molecules27030917.
9
Mechanistic Insights into Biological Activities of Polyphenolic Compounds from Rosemary Obtained by Inverse Molecular Docking.通过反向分子对接获得的迷迭香多酚类化合物生物活性的机制洞察
Foods. 2021 Dec 28;11(1):67. doi: 10.3390/foods11010067.
10
The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds.肝细胞输出载体抑制试验提高了从有毒化合物和无毒化合物中分离有毒化合物的能力。
Chem Biol Interact. 2022 Jan 5;351:109728. doi: 10.1016/j.cbi.2021.109728. Epub 2021 Oct 27.